Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study

Mitsuhiro Abe,1 Kenji Tsushima,1,2 Masashi Sakayori,1 Kenichi Suzuki,1 Jun Ikari,1 Jiro Terada,1 Koichiro Tatsumi1 1Department of Respirology, Graduate School of Medicine, Chiba University, Chuo-ku, Chiba city, Chiba 260-8670, Japan; 2Department of Pulmonary Medicine, International University of He...

Full description

Bibliographic Details

Published in:	Drug Design, Development and Therapy
Main Authors:	Abe M, Tsushima K, Sakayori M, Suzuki K, Ikari J, Terada J, Tatsumi K
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-10-01
Subjects:	idiopathic pulmonary fibrosis nintedanib triple tyrosine kinase inhibitor INPULSIS trials forced vital capacity
Online Access:	https://www.dovepress.com/utility-of-nintedanib-for-severe-idiopathic-pulmonary-fibrosis-a-singl-peer-reviewed-article-DDDT